Tetralogy of Fallot (TOF)
7
3
3
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
Effect of Exercises on Ventilatory Function in Adult With TOF
3D Modalities for Medical Student Education of Congenital Heart Disease
Effect of Parenteral Alpha-Tocopherol in the Definitive Surgery of Tetralogy of Fallot
Investigation of Tetralogy of Fallot in Neonates
An Integrated Prenatal and Postnatal Treatment Model for the Treatment of Newborns With Critical Congenital Heart Disease
Measures to Lower the Stress Response in Pediatric Cardiac Surgery